MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

NCT02407405 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

NIH

Sponsor class

Conditions

Neurofibromatosis 1 (NF1)
Plexiform Neurofibromas (PN)

Interventions

DRUG: Selumetinib

Sponsor

National Cancer Institute (NCI)